| Date | Title | Description | |
|---|---|---|---|
| 05 Apr 2024 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 28 March and 4 April 2024 | Download |
| 02 Apr 2024 | On business and financial situation | ROVI informs on the FDA’s approval of Risvan® as a treatment for schizophrenia | Download |
| 29 Mar 2024 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 22 March and 27 March 2024 | Download |
| 22 Mar 2024 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 15 March and 21 March 2024 | Download |
| 15 Mar 2024 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 8 March and 14 March 2024 | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 17 Mar 2016 | Acuerdos estratégicos con terceros | Enervit Nutrition, joint venture of ROVI and Enervit, will distribute nutritional products in Spain and Portugal | Download |
| 24 Feb 2016 | Información sobre resultados (2) | ROVI releases the press release related to the full year 2015 results | Download |
| 24 Feb 2016 | Información sobre resultados | ROVI releases the press release related to the full year 2015 results | Download |
| 24 Feb 2016 | Contratos de liquidez y contrapartida | The Company informs that it has signed a liquidity contract with JB Capital Markets, Sociedad de Valores, S.A.U. | Download |
| 24 Feb 2016 | Informe Anual de Gobierno Corporativo 2015 | ROVI releases the 2015 Annual Corporate Governance Report | Download |